November 24, 2016 - By Peter Erickson
In analysts report released on 24 November, Goodbody reiterated their Buy rating on shares of UDG Healthcare PLC (LON:UDG).
Out of 9 analysts covering UDG Healthcare PLC (LON:UDG), 8 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 89% are positive. GBX 750 is the highest target while GBX 5.15 is the lowest. The GBX 679.29 average target is 7.82% above today’s (GBX 630) stock price. UDG Healthcare PLC has been the topic of 42 analyst reports since July 31, 2015 according to StockzIntelligence Inc. The stock of Udg Healthcare PLC (LON:UDG) earned “Add” rating by Numis Securities on Thursday, May 19. The stock has “Hold” rating given by N+1 Singer on Thursday, August 6. As per Friday, September 30, the company rating was maintained by Jefferies. Berenberg maintained Udg Healthcare PLC (LON:UDG) on Friday, June 3 with “Buy” rating. The firm earned “Buy” rating on Monday, July 25 by Berenberg. The company was maintained on Thursday, August 4 by Goodbody. As per Thursday, August 6, the company rating was maintained by Jefferies. Jefferies maintained it with “Buy” rating and GBX 680 target price in Tuesday, July 26 report. The stock has “Outperform” rating given by Davy Research on Monday, October 24. Numis Securities maintained Udg Healthcare PLC (LON:UDG) on Monday, October 24 with “Add” rating.
About 393,119 shares traded hands. Udg Healthcare PLC (LON:UDG) has risen 9.66% since April 26, 2016 and is uptrending. It has outperformed by 4.25% the S&P500.
UDG Healthcare plc, formerly United Drug plc, is a healthcare services well-known provider in the Republic of Ireland, the United Kingdom, North America and Continental Europe. The company has a market cap of 1.54 billion GBP. The Firm operates in three divisions. It has a 33.85 P/E ratio. The Ashfield Commercial & Medical Services segment is engaged in the provision of sales, marketing and healthcare communications services to pharmaceutical companies, and it also provides sales teams, healthcare communications, telesales, nurse educators, medical information, pharmacovigilance, regulatory and event management services to over 300 healthcare companies in approximately 20 countries.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.